AI English summary of an SEC filing — figures as filed

The company said revenue for Q2 2025 was $18.605 billion, net income attributable to the company was $1.653 billion ($6.83 per diluted share), and Adjusted EBITDA was $3.849 billion.

8-KResults of Operations and Financial ConditionFiled Jul 25, 2025Period of report Jul 25, 2025Summary published (UTC) Oct 9, 2026

Key points

AI summary

The company said revenue for Q2 2025 was $18.605 billion, net income attributable to the company was $1.653 billion ($6.83 per diluted share), and Adjusted EBITDA was $3.849 billion.
HCA Healthcare said operating cash flow for Q2 2025 was $4.210 billion (compared with $1.971 billion in Q2), and that it repurchased 7.031 million shares at a cost of $2.505 billion.
The company presented its full-year 2025 revenue outlook at $74.00 billion to $76.00 billion (previously $72.80 billion to $75.80 billion) and its Adjusted EBITDA outlook at $14.70 billion to $15.30 billion (previously $14.30 billion to $15.10 billion).
The company said its Board of Directors declared a quarterly cash dividend of $0.72 per common share, payable on September 30, 2025 to stockholders of record at the close of business on September 16, 2025.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Q2 Revenue, Net Income and Adjusted EBITDA

The company said revenue for Q2 2025 was $18.605 billion, net income attributable to the company was $1.653 billion ($6.83 per diluted share), and Adjusted EBITDA was $3.849 billion.

Source · Based on the filing body and exhibits

Q2 Operating Cash Flow and Share Repurchases

HCA Healthcare said operating cash flow for Q2 2025 was $4.210 billion (compared with $1.971 billion in Q2), and that it repurchased 7.031 million shares at a cost of $2.505 billion.

Source · Based on the filing body and exhibits

Revised 2025 Full-Year Outlook

The company presented its full-year 2025 revenue outlook at $74.00 billion to $76.00 billion (previously $72.80 billion to $75.80 billion) and its Adjusted EBITDA outlook at $14.70 billion to $15.30 billion (previously $14.30 billion to $15.10 billion).

Source · Based on the filing body and exhibits

Quarterly Cash Dividend of $0.72

The company said its Board of Directors declared a quarterly cash dividend of $0.72 per common share, payable on September 30, 2025 to stockholders of record at the close of business on September 16, 2025.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.